Dr Cummins teaches Anatomy, Human Biology and Reproductive Biotechnology at Murdoch University in Western Australia. He has extensive experience in reproductive biology and assisted conception techniques such as in vitro fertilization (IVF). He sits on the editorial board of several top journals, including Human Reproduction and Reproductive Biotechnology Online, and chairs the Scientific Advisory Committee of the Reproductive Technology Council of Western Australia (the government body overseeing IVF clinics). He has been involved in professional editing for 10 years and has worked on about 2500 papers. He has many colleagues and friends in Asia and was a Visiting Professor at Osaka University's Genome Information Research Center in Japan in 2005. Assoc Prof Cummins began editing for the Edanz Group in 2009.

From 1993 to 2006, Dr Helliwell held positions in several research organizations as a Research Fellow in the areas of Anatomy with Radiology, Pharmacology, Neuroscience and Molecular Endocrinology. Dr Helliwell is a highly regarded and well published (12 first authored reports and numerous abstracts) scientist in her field; as well she is an invited peer reviewer for many international journals. She has strong analytical skills that she brings to the editing of manuscripts for submission to peer-reviewed journals. She joined Edanz Editing in late 2006. Her fields of editing can best be described by the following areas of competence: basic molecular and cell biology techniques, in situ hybridization, cell and tissue culture, immunocytochemistry, immunohistochemistry, immunofluorescence, Western blotting and zymography, receptor autoradiography and receptor binding assays, mammalian neuroanatomy and neuroendocrinology.

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

Dr Huxley obtained both her undergraduate and graduate qualifications from Oxford University in Physiological Sciences and Epidemiology, respectively. In 2002 she was appointed as a Senior Research Fellow at the George Institute at the University of Sydney, Australia. In 2007, Dr Huxley was appointed Conjoint Associate Professor in the Faculty of Medicine, University of Sydney and Director of the Nutrition and Lifestyle Division within the George Institute. Over the past 10 years, she has published more than 90 research articles, many in high impact journals including The Lancet, British Medical Journal, Circulation and JAMA and is a regular invited speaker at international conferences. Dr Huxley has also been the recipient of several prestigious research awards and fellowships. Dr Huxley began work as a writer, editor and consultant with the Edanz Group in 2010.

Dr Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr Smith has been a Research Assistant at the Queen Mary, University of London’s Institute of Cellular and Molecular Sciences, where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex University. Dr Smith has studied editing and design skills in relation to publication at the London School of Journalism, and is now a full-time medical writer. Dr Smith gained extensive experience in medical and scientific communications while employed at the internationally recognized agency Medicus International, where he worked on a range of medical communications projects for several well-known pharmaceutical companies. He joined the Edanz Group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector in assisting clients to achieve their publication goals.

For three years, Dr Furness was a Post-doctoral Research Fellow at the Beatson Institute for Cancer Research, Glasgow, where she used extensive molecular genetic techniques to examine the factors influencing the growth of hematopoietic stem cells, with relevance to the development of cancers such as leukemia. Later Dr Furness was a researcher at Glasgow University where she analyzed the energetic requirements of seabirds, using field observations, analysis of radioisotopes from blood samples and metabolic monitoring of birds in respirometers. Dr Furness is a scientific editor with extensive experience of abstracting, indexing and editing scientific papers on a wide range of topics including general medicine, pharmacology and genetics, with personal experience of active scientific research and the publishing of research papers. From 1993 to 2007, Dr Furness was a Specialist Medical Indexer at Thomson Scientific. She began working with Edanz Editing in 2007.

Prof McKune is an Associate Professor in the Department of Biokinetics, Exercise and Leisure Sciences at the University of KwaZulu-Natal, South Africa. His PhD thesis examined immune and inflammatory responses to strenuous exercise. He is a South African National Research Foundation rated researcher and is a past co-leader of National Research Foundation Niche Area examining the effect of exercise on immune and inflammatory responses in healthy adults. Prof McKune’s research is currently supported by National Research Foundation and Medical Research Council competitive research grants. His research interests include the immune/inflammatory response to exercise with applications to the prevention and treatment of chronic diseases of lifestyle, and the promotion of optimal adaptation to strength and conditioning training. He has published 28 articles on topics including heart rate variability, hypertension, obesity, exercise-induced muscle damage, immune and inflammatory responses to exercise, and the impact of exercise on motor and cognitive function. Prof McKune began working with the Edanz Group in 2011.

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

After obtaining a BA and PhD in zoology from the University of Oxford, Dr Prosser joined the Medicine Publishing Company, Abingdon, UK, (now part of Elsevier Health Sciences) as a Staff Editor of medical educational publications. In 1998, she became Managing Editor of the journal Medicine, a position she held until 2006, when she began as a freelance science and medical writer and manuscript editor. Dr Prosser, an accomplished and highly experienced biomedical and health sciences editor and writer, began working with Edanz Group in 2006.

Dr Rosa worked as a large animal veterinarian at Cornell University (USA) and as an equine veterinarian at Massey University (NZ) before beginning her PhD studies. Her skills in veterinary medicine range from medicine and surgery to herd health and animal welfare. Her present PhD research is in the area of developmental origins of health and disease; specifically, the effects of maternal exercise on offspring development and later-life health in a rat model. Her PhD research integrates endocrinology, reproductive biology, exercise physiology, and imaging techniques to examine the musculoskeletal and metabolic health of her trial animals. This work has led to several publications in the American Journal of Physiology. Dr Rosa joined the Edanz Group as an editor and expert reviewer in 2011.

Dr Bradshaw is a clinical specialist with a strong background in biomedical science and healthcare related research. He is a member of the European Medical Writers Association (EMWA), and has published over 17 scientific papers. In 2007/8, Dr Bradshaw sat on the board as an elected member of both the Royal College of Physicians guideline development and steering groups, leading to the publication of National Health Service guidelines. He also first-authored the UK national guidelines on “Occupational Visual Standards” for the Royal College of Ophthalmologists. He is a peer reviewer for several top journals including: the American Journal of Ophthalmology, Aviation Space and Environmental Medicine and the British Journal of General Practice. Dr Bradshaw is a specialist editor across a wide variety of medical and bioscience topics. He joined the Edanz Groups as an editor and writer in 2010.

Dr Shoemaker's scientific background is in pharmacology and toxicology with a focus on neurodegenerative diseases, endocrine disorders and gastroenterology. For her PhD, she investigated and published on the involvement of the second cannabinoid receptor (CB2) in the pathology of amyotrophic lateral sclerosis. For her post-doctoral fellowship at Emory University, she studied the pathophysiology of enteric axons during the early stages of diabetes. Dr Shoemaker is an experienced editor and began working for the Edanz Group in early 2009.

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

Dr Patel is a neuroscientist interested in central nervous system degeneration and mental illness. For his doctoral thesis he developed a mouse gene-knockout model for the human neurological disorder aceruloplasminemia. Subsequently, as a research fellow at the Department of Cell Biology at Harvard Medical School he studied the molecular signaling cascades involved in nerve cell migration. Dr Patel has recently focused his research on the molecular genetics of psychiatric illness as an associate at the Douglas Mental Health Institute in Montreal. His studies center on microRNA signaling networks involved in major depression and suicide. Dr Patel has published a number of first-author articles in high-impact journals, including The Journal of Biological Chemistry and The Journal of Neuroscience. He began editing for the Edanz Group in 2011.

Dr Reynolds initially practiced in Medical Oncology and then Psychotherapy. After retiring from clinical practice in 2003 she began a new career in medical editing. Most of her work has been for Japanese and Chinese authors. A successful author, Dr Reynolds has published 13 articles in peer-reviewed journals, and two books. Dr Reynolds joined the Edanz Group as an editor and writer in 2011 and, though with a clinical focus, works in a broad range of medical fields.

Ms Schatken’s university studies focused on medical technology. After graduation she worked for six years in specialized hematology and research laboratories: the Albany (NY) Medical Center, Mallory Institute (Boston), Tufts Medical School (Boston), Upstate Medical Center (State University of New York, Syracuse, NY), and the Jewish Medical Center (New York). She then went into medical publishing at Harper & Row, later moving to the magazine Medical World News. In 1970 she began working as an independent medical editor and writer. Her work has included preparing reports for physicians, pamphlets/booklets for pharmaceutical houses, abstracts of medical articles, and conference presentations. She has also copyedited medical and scientific journals and books for a variety of publishers, including Springer (New York and Tokyo), Oxford University Press, Little Brown, Raven Press, Harper & Row, Appleton-Century Crofts, and Churchill Livingstone. Ms Schatken began working as an editor and writer with the Edanz Group in 2010.

Dr Morben has six years of experience in veterinary medicine. She currently works as a general practitioner in the United States. In addition, Dr Morben has extensive experience editing and proofreading a wide variety of research manuscripts and is a member of the American Medical Writers Association. Dr Morben began working as an editor with the Edanz Group in 2010.

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

Dr Lutze's graduate work was in vision science. Her studies involved the assessment of changes in color vision with disease and the genetic basis of color vision. She worked alongside ophthalmologists during post-doctoral training and has experience with ophthalmological clinical activities and research. She later worked with an ophthalmologist studying diabetic retinopathy and other retinal diseases. Dr Lutze works as a language editor for a gastroenterology journal based in Beijing, China, and began working as an editor with the Edanz Group in 2009.

Dr McAlpine's PhD research focused on the effects of inflammation, specifically Tumor Necrosis Factor, on the progression of neurodegenerative diseases. This research focused mainly on Alzheimer's disease, with some work on Parkinson's disease. She made extensive use of rodent models of these diseases, and administered both drugs and gene therapy vectors to the brains of affected animals. She has published both primary research articles and reviews on this topic. After her PhD, Dr McAlpine completed a postdoctoral fellowship studying autophagy in the UK. Dr McAlpine joined the Edanz Group as an editor in 2011.

Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.

Dr Komolova’s doctoral dissertation focused on characterizing the role of the kidneys in blood pressure regulation in various disease states (hypertension, salt-sensitivity, and obesity). She also investigated the effects of antihypertensive drugs and lifestyle changes on cardiovascular and metabolic function. She is proficient in numerous research techniques, ranging from molecular to whole-animal methodologies. Her work has been published in scientific journals including Hypertension, the Journal of Hypertension, and the International Journal of Obesity. Currently, she is an Adjunct Professor and Research Facilitator in the Department of Pharmacology & Toxicology at Queen’s University, and a freelance medical writer. Dr Komolova began working with the Edanz Group in 2010.

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr Bijur's work is on neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and investigations into brain metabolic functions. Dr Bijur has extensive experience in the areas of psychiatry, including schizophrenia and bipolar disorder, metabolic disorders such as diabetes, and in oncogenesis and carcinogenesis. He has thorough understandings of cell culture techniques, molecular biology techniques, and rodent animal models. His personal research has been funded by the U.S. National Institutes of Health and the National Alliance for Research on Schizophrenia and Depression. Dr Bijur has authored over 32 peer-reviewed publications, and has presented at numerous scientific conferences including the Society for Neuroscience and the American Association for Cancer Research, among others. He also serves as a reviewer for several biomedical journals and granting agencies. Dr Bijur joined the Edanz Group as an editor and medical writer in 2010.

Dr Piatek’s scientific background is in forest ecology and soils. Her research interests are on the effects of disturbance on nutrient cycling in forests and nutrient exports from forested watersheds. She has conducted research in conifer and broadleaf natural and plantation forests using a combination of field and lab approaches including isotopic techniques, modeling, and survey instruments. Dr Piatek is the author of several scientific manuscripts on nutrient cycling processes in forest floors, and element dynamics in export waters. Dr Piatek also has a research interest in understanding the effects of nutrition on human health and well-being. She has lectured courses in Soils, Forest Soils, Forest Management, and Global Forest Resources. Her research findings are frequently presented at the annual meetings of the Soil Science Society of America—an organization in which she was elected and served as Chair for the Division of Forest Range and Wildland Soils. She is also a frequent reviewer for several soils, water, and forest ecology journals. Dr Piatek joined the Edanz Group as an editor in 2011

Following the completion of her PhD in biochemistry, Dr Bell was a post-doctoral fellow in the department of Medical Biochemistry at Gothenburg University, Sweden, and then in the department of Behavioural Neuroscience at OHSU, USA. Her postgraduate research focused on the isolation, regulation, action and biological effects of constitutively active MAPK molecules in a eukaryotic yeast model with reference to mammalian MAPKs. Her first post-doctoral post investigated the regulation of the transcription factor FoxC2 and the role of the PKA regulatory subunit RIIβ in adipocyte metabolism. This research had direct relevance to obesity and Type II diabetes. Following this research she then moved into the field of biochemical neuroscience, studying the signaling pathway of the D2 dopamine receptor in relation to receptor tyrosine kinases (RTKs) and MAPK in primary neuronal cultures and in vivo. Throughout her career Dr Bell gained experience with a wide range of molecular biology techniques including genetic manipulation, yeast and mammalian cell culturing, animal breeding and dissection, DNA and mRNA analysis, molecular staining, imaging and protein biochemistry. Dr Bell has published 6 peer-reviewed papers, 3 as first author. Dr Bell also holds a patent related to her development of constitutively active MAPKs. Her current interests include the fields of scientific communication and education. Dr Bell joined the Edanz Group as an editor in 2010.

Dr de Boo is a physiologist with a particular interest in fetal growth and metabolism. Her PhD thesis was entitled “Aspects of Nitrogen Metabolism in Intrauterine Growth Restriction,” focusing primarily on urea cycle disorders in growth-restricted human neonates and fetal sheep. She has since completed a post-doctoral study on the development of intrauterine treatments for intrauterine growth restriction by hormonal supplementation. Dr de Boo has extensive experience in writing and editing both scientific and non-scientific manuscripts and is now a full-time freelance editor.

For his PhD, Dr Wilhelmi researched the bioremediation of heavy metals from contaminated mine waste waters. He then worked in a doping control Research and Development laboratory investigating immunological techniques for the detection of corticosteroids. On returning to academia his research has been in a number of biochemical fields, including P450 drug metabolism, DNA barcoding, continuous fermentation and bioremediation. His current research involves the isolation of liver microsomes, cloning, expression and characterization of P450 isoforms. This research is aimed at determining the metabolism of various novel compounds and drugs of abuse. A second research interest investigates the potential of using DNA markers for determining the diet of elusive and dangerous herbivores on South African game reserves. In particular the work has investigated the rbcL gene as a biomarker for plants consumed by these herbivores. Dr Wilhelmi is a senior lecturer at Rhodes University, where he teaches metabolism, analytical techniques and forensic biochemistry. He has presented at conferences and has published in the areas of chromatography and analytical biochemistry, conservation biochemistry, and enzymology. Dr Wilhelmi joined the Edanz Group as an editor in 2012.

Prof Takemoto is a University Distinguished Professor Emeritus at Kansas State University, Manhattan, KS, USA. He has extensive experience in the cell biology and protein chemistry of the eye, which he has studied for over 30 years. His research has been continuously funded by the National Institutes of Health of the US. He has served on numerous national and international boards dealing with vision research, including the Board of Scientific Counselors of the National Eye Institute, Lens & Cataract Panel of the National Eye Institute, and the Board of Directors of the Association for Research in Vision & Ophthalmology (ARVO). Prof Takemoto, though US-born, traces his ancestry back to Japan and has conducted research and traveled extensively in Japan as a Fellow of the Japan Society for the Promotion of Science. He has published over 150 peer-reviewed manuscripts, and joined the Edanz Group as an editor in 2011

Dr Fayle’s PhD focused on Food Chemistry. Her postdoctoral research was done in the Department of Food and Nutrition at the University of Reading, UK. She then worked as a scientist for Crop and Food Research in New Zealand. Dr Fayle’s laboratory skills include both traditional gel electrophoresis and capillary electrophoresis techniques, HPLC, organic synthesis, protein purification and identification, and NMR. Dr Fayle has expert knowledge of the Maillard Reaction, and is the author of a Royal Society of Chemistry monograph on this reaction. She also has authored twenty related publications, and has been an invited speaker at international conferences in her field of study. She began working with the Edanz Group as an editor in 2010.

Currently, Dr Werry is at Queen Mary University of London studying dentistry. Prior to this, he worked for GlaxoSmithKline Ltd in the Neurosciences Centre of Excellence in Drug Discovery in Harlow, UK. Dr Werry studied G protein-coupled receptor (GPCR) pharmacology and cellular signaling as part of his PhD in a thesis entitled "The effects of crosstalk on GPCR-mediated calcium signaling pathways". He has also worked in one of the premier pharmacology labs in the world with Prof Arthur Christopoulos at Monash University, Melbourne, Australia, studying cellular signaling by variants of the serotonin 5HT2C receptor and the pharmacology and cell biology of mitogen-activated protein kinase signaling. Dr Werry's work has produced numerous publications including original research papers and authoritative reviews on calcium and ERK signaling and 5HT2C receptor RNA editing. His areas of expertise include pharmacology, neuroscience, G protein-coupled receptors, and cellular signaling. Dr Werry began working with the Edanz Group as a writer and editor in 2010.

Dr Lai qualified in medicine and underwent training in internal medicine, followed by specialization in oncology. Dr Lai was later responsible for clinical research programs of novel signal disrupting agents for solid tumors and hematological malignancies at a global pharmaceutical company. He has extensive experience in the process of drug development, from phase 1 dose-escalation studies to large-scale, phase 3 randomized controlled trials and post-marketing surveys. In addition, he is also experienced in regulatory and health economic issues related to pharmaceutical products. Dr Lai is an experienced editor and began editing for the Edanz Group in 2010.

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

Dr Sheen is a postdoctoral research fellow at San Diego State University, studying microbial pathogenesis. Her work encompasses microbial niche establishment as well as penetration of the blood-brain barrier. She also has two patents for the development of novel therapeutic agents for treatment of MRSA infections. Dr Sheen carried out her PhD research at AgResearch in Lincoln, New Zealand, focusing on applying genetic techniques to improve the soil survival of a microbial biocontrol agent. Her other research has involved the phylogenetic analysis of Antarctic notothenioid fish and species evolution. Dr Sheen began editing for Edanz Editing in 2011.

After graduating, Dr Charbonneau spent 10 years involved in general surgery, preventive medicine, behavior counseling and diagnostics and treatments related to dermatology, gastroenterology, endocrine and emergency patients in an animal veterinary practice. In 2000, Dr Charbonneau began a 10 year focus on emergency medicine and surgery and completed a one-year term teaching equine locomotor diseases to students of massage therapy. Her experience in emergency medicine includes critical care of trauma patients and patients in cardiac, liver and renal failure, infectious disease, resuscitation and transfusion medicine, neurological and endocrine emergencies as well as surgical correction of gastric dilatation and volvulus, ruptured splenic masses, gastrointestinal foreign bodies, bullet wounds, fractures and wound repair. Currently, Dr Charbonneau works as a relief veterinarian, and has an interest in clinically focused communication. Dr Charbonneau joined Edanz as an editor in 2011.

Dr Cleary is a biomedical scientist with a special interest in cancer research and chronic disease. Her doctoral thesis was entitled “From chromaffin cells to phaeochromocytoma: insight into the sympathoadrenal lineage”. Dr Cleary was a Post Doctoral Fellow with the National Institutes of Neurological Disorders and Stroke (NIH), where she was the lead researcher on a project investigating novel strategies for the treatment of metastatic kidney disease. Dr Cleary has an extensive history of research in cancer tumor biology and an interest in the developmental origins of cancer, especially those related to mutations of the von Hippel-Lindau gene. Dr Cleary has an interest in health policy and was a Fellow with the Fogarty International Center at the NIH. During this time she was involved in a number of global health policy projects. Dr Cleary has published a number of articles in peer-reviewed journals in addition to other science writing for a non-technical audience. Dr Cleary began working as an editor for the Edanz Group in 2010.

Dr Eastman has wide clinical care experience. He was board certified by the American Board of Family Practice in 1977 and by the American Board of Emergency Medicine in 1981. He has been involved in paramedic training and emergency care planning. Dr Eastman has been a Federal Aviation Administration Senior Aviation Medical Examiner, a safety advisor for power boat racing and an expert witness in cases of alleged malpractice. In 1986 he was president of the Orange County (California) chapter of the American Academy of Family Practitioners. In 1992 Dr Eastman joined a rural general practice in New Zealand, leading development of its computerized database and of X-ray services. He has written a health care column and has published on medical ethics. Dr Eastman joined the Edanz Group as an editor in 2011.

Ms LaPoint is a science and medical writer-editor with experience in a wide range of medical and life science topics. Her master’s thesis involved the development of antimicrobial agents to prevent and treat antibiotic-resistant bacteria. Ms LaPoint has taught biology and microbiology at the University of North Carolina-Greensboro, where she also conducted research investigating links between obesity, inflammation, and insulin resistance. She has co-authored seven scientific manuscripts published in peer-reviewed journals and one scientific book chapter. Ms LaPoint also has a post-graduate biomedical writing certificate and is a board-certified editor in the life sciences (ELS). As an editor she has edited hundreds of research manuscripts; as a writer she has written about health and medical topics for the pharmaceutical and biotechnology industries. She began working as an editor and writer with the Edanz Group in 2010.

Mr Gorman has 35 years of experience in the healthcare system in Canada. He has worked as a project manager, research coordinator, department head, consultant, respiratory therapist, and more recently as a medical editor. Mr Gorman is familiar with AMA guidelines and ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. For the past four years he has worked as a freelance medical editor for medical researchers at the McGill University and University of Montreal Research Centers in Montreal, QC, Canada. Mr Gorman joined the Edanz Group as an editor in 2011.

Mr Pishief, a barrister and solicitor, is a legal editor and writer of manuscripts for publication in text books, legal bulletins, and online on global legal platforms. His background in both law and science, with his biomedical science study focusing on molecular pathology, specifcally pathology (including histology) of the brain, heart, liver, kidney, bone, blood, and lymphoid system; genetics, including sequencing, bioinformatics and genetic disorders; biomedical laboratory techniques, with a focus on DNA/RNA extraction and isolation, reverse transcription, PCR, and gel electrophoresis; metabolism; immunology; medical microbiology; and physiology (including neurophysiology and neuroimaging). An experienced report and abstract writer, Mr Pishief joined the Edanz Group as an editor in 2011.

Dr Janiszewski is a well published author with 16 peer-reviewed reports, plus abstracts and a book chapter on topics including obesity, body composition, physical inactivity, cardiovascular disease, type-2 diabetes, sexual dysfunction, diet, exercise, and obesity management. His research has been published in high impact journals including Diabetes Care, Archives of Internal Medicine, the Journal of Clinical Endocrinology and Metabolism, the Journal of Sexual Medicine, Diabetologia, and the American Journal of Clinical Nutrition. Dr Janiszewski now works as a medical writer and has a medical blog and podcast on PLoS Blogs Network. He is an expert in social media and currently holds the position of Health/Clinical Research Editor at ResearchBlogging.org. Dr Janiszewski began working with the Edanz Group as a medical writer in 2009.